Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer

Clinical trial NCT02299141 · COMPLETED

Trial details

NCT number: NCT02299141
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Non-Small Cell Lung Cancer Nonsmall Cell Lung Cancer

Start date: 2015-05-07
Primary completion: 2020-01-09
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.